Stockscreener 앱 받기
4.82
7.11%
0.32
Monte Rosa Therapeutics Inc (GLUE) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
72.69%
23.19
|
84.93 | 60.65 | 9.216 | 4.695 |
Operating Expenses
|
5.25%
38.75
|
40.89 | 47.64 | 35.74 | 37.34 |
| Benefits Costs and Expenses |
7.88%
34.29
|
37.22 | 45.05 | 33.00 | 34.75 |
| Costs And Expenses |
7.88%
34.29
|
37.22 | 45.05 | 33.00 | 34.75 |
| Operating Income/Loss |
135.32%
-15.55
|
44.04 | 13.00 | -26.53 | -32.64 |
| Nonoperating Income/Loss |
21.44%
4.458
|
3.671 | 2.597 | 2.739 | 2.584 |
| Income/Loss From Continuing Operations Before Tax |
123.26%
-11.10
|
47.71 | 15.60 | -23.79 | -30.06 |
| Income Tax Expense/Benefit |
45.86%
1.199
|
0.822 | 2.164 | 0.071 | 0.252 |
| Income/Loss From Continuing Operations After Tax |
126.22%
-12.29
|
46.88 | 13.44 | -23.86 | -30.31 |
|
Net Income/Loss
|
126.22%
-12.29
|
46.88 | 13.44 | -23.86 | -30.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.05%
82.19
|
82.15 | 2.7364 | 82.01 | 71.23 |
| Diluted Average Shares |
0.93%
82.19
|
82.96 | 2.7364 | 82.01 | 71.23 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.94%
1.72%
자본화:
|
볼륨(24시간):